CancerInside is an examination that can screen for the likelihood of developing familial cancer. Theragen Bio analyzes 31 genetic variations that can cause familial cancer using its own NGS technology. This examination conducted as a preventive measure for the early detection of cancer with the prediction of cancer incidence risk. It also increases treatment effects, minimizes side effects, and saves costs with targeted anticancer prescriptions and customized treatments that consider genetic differences.
Breast cancer, Colorectal cancer, Kidney cancer, Melanoma, Ovarian cancer, Pancreatic cancer, Uterine cancer), Multiple cancer (Le-Fraumeni syndrome, Peutz-Jeghers syndrome, Von Hippel-Lindau sydrome, ynch syndrome etc.
Production of sequencing library
Gene sequence analysis
Sequencing data analysis
Confirmation of sequencing mutations
Causal mutation analysis
Next Generation Sequencing(NGS) Systems
Tissue or DNA